Proteomic Analysis Services
Closed Pre-Solicitation Posted
Not the latest version. See the latest pre-solicitation from .
- Solicitation number
- 75N95025R00048
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621991 Blood and Organ Banks
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute on Drug Abuse (NIDA) and National Institute on Aging (NIA), both part of the Department of Health and Human Services' National Institutes of Health, intends to procure proteomic analysis services to identify biomarkers associated with Alzheimer's Disease and Related Dementias. The services will utilize advanced proteomic analysis platforms including NuLISA and Seed Amplification Assay (SAA), along with whole-genome sequencing using the Illumina NovaSeq 2000 platform. The vendor must demonstrate proficiency with cerebrospinal fluid and plasma samples from subjects with neurodegenerative diseases, maintain quality control bridging cohorts of 30 samples, and provide comprehensive data analysis with results delivered via CSV and PDF files. This pre-solicitation notice was posted on August 20, 2025, with a due date of September 4, 2025, and the government intends to award the contract on or around September 15, 2025. The procurement is being conducted under FAR Part 13 Simplified Acquisition Procedures as a non-competitive, single-source acquisition from Banner Sun Health.
This opportunity does not include any set-aside designations and is classified under NAICS code 621991 (Blood and Organ Banks) with a size standard of $40 million. Banner Sun Health has been identified as the intended sole source contractor for this procurement. The contract period spans three years from September 15, 2025, to September 14, 2028, structured with a base year and two option years. The vendor will be required to process up to 2,400 sample libraries per week and must analyze cohorts independently within the same batch of reagents while running pooled government samples with known analytes. No travel is required for vendor employees under this contract arrangement.
Notice text
PRE-SOLICITATION NOTICE OF INTENT
NON-COMPETITIVE
Solicitation: 75N95025R00048
Title: Proteomic Analysis Services
INTRODUCTION
PURSUANT TO FAR Subpart 5.2—Synopses of Proposed Contract Actions, THIS IS A PRE-SOLICITATION NOTICE OF A PROPOSED CONTRACT TO ACTION.
THIS IS A PRE-SOLICITATION NON-COMPETITIVE NOTICE OF INTENT TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institute on Drug Abuse (NIDA), National Institute on Aging (NIA) intends to intends to solicit by a request for quotation from Banner Sun Health for award on or around September 15, 2025. The purpose of this purchase order will be to provide the National Institute on Aging (NIA) with proteomic analysis services.
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
The intended procurement is classified under NAICS code 621991 – Blood and Organ Banks with a Size Standard of $40M.
REGULATORY AUTHORITY
The resultant contract will include all applicable provisions and clauses of the Federal acquisition Requlation (FAR) in effect through the current Federal Acquisition Circular (FAC).
STATUTORY AUTHORITY
This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures. Contracts awarded using FAR Part 13—Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6—Competition Requirements. FAR Subpart 13.106-1 (b) Soliciting from a single Source provides that: For purchases not exceeding the simplified acquisition threshold,
Contracting officers may solicit from one source IF the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name OR industrial mobilization).
DESCRIPTION OF REQUIREMENT
Purpose and Objectives
The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Institute on Agign (NIA), has a requirement for proteomic analysis services.
The NIH Intramural Center for Alzheimer’s Disease and Related Dementias is an interdisciplinary initiative that is dedicated to advancing our understanding and treatment of Alzheimer’s disease and related dementias (AD/ADRD). Biomarkers play a critical role in understanding, diagnosing, and monitoring disease progression and therapeutic efficacy. This requirement for NULISA testing aims to identify biomarkers which will provide information about underlying molecular changes associated with Alzheimer’s Disease and Related Dementias in well characterized samples from patients.
Delivery or Deliverables
Please see the attached Statement of Work for further details.
CLOSING STATEMENT
THIS SYNOPSIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. However, interested parties may identify their interest and capability to respond to this notice.
A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.
Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.www.sam.gov.”
All responses must be received by Thursday, September 4, 2025 at 9:00 a.m., Eastern Standard Time, and reference number 75N95025R00048. Responses may be submitted electronically to Robin Knightly, Contract Specialist, at Robin.Knightly@nih.gov.
Fax responses will not be accepted.
Extensions to the deadline will not be granted.
Please contact Robin Knightly, Contract Specialist, at Robin.Knightly@nih.govor (301) 827-5302 with any questions.
Files
| File | Type | Posted |
|---|---|---|
| 75N95025R00048.SOW.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Proteomic Analysis Services | Pre-Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity